Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Silver citrate is an experimental small molecule compound classified as a tricarboxylic acid derivative. It is the silver salt of citric acid and is also known as trisilver citrate or 2-hydroxy-1,2,3-propanetricarboxylic acid silver salt. Silver ions in this compound are stabilized by the citrate counter ion, which enhances their antimicrobial properties by increasing permeability into bacteria and preventing oxidation of the ionic form. The primary mechanism of action involves the release of antimicrobial silver ions (Ag+), which disrupt bacterial cell function through multiple pathways including binding to thiol groups in proteins (leading to protein denaturation) and interacting with DNA to inhibit replication. Silver compounds are under research for their potential use as antimicrobial agents due to rising resistance against conventional antibiotics[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on silver citrate.